We collect basic website visitor information on this website and store it in cookies. We also utilize Google Analytics to track page view information to assist us in improving our website.
We collect basic website visitor information on this website and store it in cookies. We also utilize Google Analytics to track page view information to assist us in improving our website.
In a groundbreaking study conducted at The University of Texas MD Anderson Cancer Center, researchers reveal the positive impact of enhanced infection prevention and control (IPC) measures implemented during the COVID-19 pandemic. The study, published in the American Journal of Infection Control, demonstrates a significant reduction in healthcare-associated infections (HAIs) and respiratory viral infections (RVIs) due to strict IPC interventions.
Led by Dr. Roy F. Chemaly, the study analyzed data from approximately 30,000 patients admitted annually at the cancer center. Enhanced IPC practices, including rigorous personal protective equipment use, universal masking, and visitor restrictions, were deployed starting March 2020. The results indicate a noteworthy decrease in laboratory-identified C. difficile infections, central line-associated bloodstream infections, and overall nosocomial RVIs.
These findings underscore the critical role that evidence-based IPC practices play in reducing infections, especially in vulnerable patient populations. The study suggests that prioritizing and investing in IPC measures can yield positive outcomes, even in challenging situations like the COVID-19 pandemic. To dive deeper into the study's comprehensive results and insights, read the full article here.
